• LAST PRICE
    0.0001
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0001
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    High 0.0001
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMMB
Immunotech Laboratories Inc
57.5K
0.0x
---
United StatesAMPE
Ampio Pharmaceuticals Inc
85.3K
0.0x
---
United StatesGBLX
GB Sciences Inc
40.7K
0.0x
---
United StatesVOQP
Vioquest Pharmaceuticals Inc
43.1K
0.0x
---
United StatesHDVY
Health Discovery Corp
41.2K
0.0x
---
United StatesAMBS
Amarantus Bioscience Holdings Inc
63.1K
0.0x
---
As of 2024-11-23

Company Information

Immunotech Laboratories, Inc. (Immunotech) is a drug development company that focuses on research and development in the biotechnology field. The Company is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.

Contact Information

Headquarters
116 W. Stocker StreetGLENDALE, CA, United States 91202
Phone
818-421-2090
Fax
626-538-4779

Executives

Vice Chairman of the Board, Chief Science Officer
Harry Zhabilov
Director
Roscoe Moore

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$57.5K
Revenue (TTM)
$4.0K
Shares Outstanding
575.0M
Immunotech Laboratories Inc does not pay a dividend.
Beta
---
EPS
$-221.70
Book Value
$-6.96
P/E Ratio
0.0x
Price/Sales (TTM)
14.4
Price/Cash Flow (TTM)
---
Operating Margin
-1,032,425.00%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.